http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0504559-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89ac64d62baaa791ac712c93832985fd |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784 |
| filingDate | 2005-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d34a692375d2571d14f7983890819930 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c1cdd2a551dfb388825519e0444f9d1 |
| publicationDate | 2018-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0504559-B1 |
| titleOfInvention | process of obtaining dendritic cells |
| abstract | Process of Obtaining Dendritic Cells and Vaccine or Immunomodulatory Product Employing These Dendritic Cells The present invention is directed to the process of obtaining dendritic cells from differentiated and activated precursor cells by employing melatonin or its precursors, metabolites, or catabolites and immunomodulatory product. employing these obtained dendritic cells. The process of preparing dendritic cells according to the invention comprises the steps: (a) separation of precursor cells (b) activation and differentiation of precursor cells obtained by culturing them in the presence of melatonin or its precursors, or metabolites or catabolites . |
| priorityDate | 2005-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 245.